Aims Biochar affects the progress of plant diseases caused by soilborne pathogens, frequently featuring Ushaped biochar dose/disease response curves. This study tested this phenomenon in common bean (Phaseolus vulgaris L.) with several biochars. Methods Four biochars prepared from two feedstocks (eucalyptus wood and greenhouse wastes) each at 350 and 600°C were tested on bean seedling growth and infection caused by Rhizoctonia solani at concentrations of 0-3 % by weight. Biochar direct toxicity to R. solani was quantified in vitro. Results In general, lower concentrations (≤1 %) of biochar suppressed damping-off, whereas higher concentrations (3 %) were ineffective at disease protection. Plant growth in the absence of the pathogen was generally improved at all doses by the four biochars. Maximum growth response (G-R max ) generally occurred at higher biochar doses than maximum disease reduction (D-R max ). Direct toxicity to the pathogen could not explain disease reduction. Conclusion Inverted U-shaped biochar dose/plant growth and biochar dose/disease reduction curves are emerging as common patterns in biochar/crop/pathogen systems. Frequently, the inflection between growth promotion and suppression occurs at different doses than the inflection between disease suppression and promotion. We term this the "Shifted R max -Effect". As there is no simple rule-of-thumb for crop/soil/biochar/dose/ pathogen combinations, the possible effects of biochar on plant pathogens should not be overlooked.
AbbreviationsAUMPC Area under mortality progress curve CFU Colony forming units EC50Effective concentration for 50 % growth inhibition Plant Soil
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.